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Ergotism
Giovanni Brancaccio, MD, Giovanni M. Celoria, MD, and Emilio Falco, MD, La Spezia, ItalyA 50-year-old woman with a 60-pack-year history of smoking was
admitted with bilateral critical leg ischemia. Her medical history was
unremarkable except for migraine headaches treated with self-
administered ergot-containing medication. She complained of rest pain
and paresis of the toes on the right and tingling and numbness of the foot
on the left. Femoral pulses were diminished, and popliteal and tibial were
absent bilaterally. On the right foot, Doppler signals were absent; whereas
on the left, she had an ankle-brachial index (ABI) of 0.30. An angiogram
documented diffuse vasospasm. The superficial femoral and popliteal
arteries had a “threadlike” appearance (Cover), with distal occlusion on
the right (A).
The patient was treated with an infusion of iloprost and low-
molecular-weight heparin. After 7 days, the spasm improved on the left;
but on the right, it progressed with ischemic changes of the skin (B). A
right laparoscopic lumbar sympathectomy was performed. At the
1-month follow-up, the ABI was 1.0 bilaterally. A duplex ultrasound scan
showed a 4.5-mm right popliteal artery with biphasic flow (C). Her ulcers
healed during the next 3 months.
Ergotism is a rare cause of arterial insufficiency. It occurs in 0.001% to
0.002% of patients receiving ergot derivatives, primarily for treatment of
migraine. Ergot preparations may cause widespread systemic arterial
vasoconstriction and can result in organ ischemia. Ergotism most com-
monly involves the extremities, particularly the femoral arteries. Leg
ischemia with pallor, coolness, and numbness progressing to rest pain are
common features. Ischemic ulcers and gangrene may develop. Chronic
lower extremity ischemia with claudication and iliac arteries dissection are
also reported.1,2
The cornerstone of therapy in ergot toxicity is to discontinue all ergot-
containing medications as well as caffeine and smoking. If limb ischemia
persists, other conservative treatment options include nifedipine, sodium
nitroprusside, prazosin hydrochloride, prostaglandins, and sympathectomy.
None has emerged as a treatment of choice. Long-term results of chemical
sympathectomy remain inconsistent, and ureteral damage, retroperitoneal
abscess, and fibrosis are reported. Angioplasty in the presence of vasospasm
carries the risk of intimal tears that may lead to thrombosis and should be
avoided.
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